Trade-Ideas LLC identified

Vascular Solutions



) as a strong and under the radar candidate. In addition to specific proprietary factors, Trade-Ideas identified Vascular Solutions as such a stock due to the following factors:

  • VASC has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $6.4 million.
  • VASC has traded 28.3134000000000014551915228366851806640625 options contracts today.
  • VASC is making at least a new 3-day high.
  • VASC has a PE ratio of 94.
  • VASC is mentioned 0.74 times per day on StockTwits.
  • VASC has not yet been mentioned on StockTwits today.
  • VASC is currently in the upper 20% of its 1-year range.
  • VASC is in the upper 35% of its 20-day range.
  • VASC is in the upper 45% of its 5-day range.
  • VASC is currently trading above yesterday's high.

TheStreet Recommends

'Strong and Under the Radar' stocks tend to be worthwhile stocks to watch for a variety of factors including historical back testing and price action. Market technicians refer to such stocks as being in an accumulation phase before a mark-up and peak. Traders and hedge funds have frequently found that these types of stocks continue to build a solid price base and then ultimately spike higher and peak when others 'discover' how good the stock is performing. By leveraging the social discovery aspect of StockTwits we are highlighting stocks that don't currently receive much attention from retail investors, but we suspect may soon garner more attention.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in VASC with the Ticky from Trade-Ideas. See the FREE profile for VASC NOW at Trade-Ideas

More details on VASC:

Vascular Solutions, Inc., a medical device company, provides clinical solutions for treating coronary and peripheral vascular disease worldwide. VASC has a PE ratio of 94. Currently there are 2 analysts that rate Vascular Solutions a buy, no analysts rate it a sell, and none rate it a hold.

The average volume for Vascular Solutions has been 140,000 shares per day over the past 30 days. Vascular has a market cap of $736.5 million and is part of the health care sector and health services industry. The stock has a beta of 1.03 and a short float of 6.3% with 7.15 days to cover. Shares are up 23.3% year-to-date as of the close of trading on Friday.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.


TheStreet Quant Ratings

rates Vascular Solutions as a


. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and weak operating cash flow.

Highlights from the ratings report include:

  • VASC's revenue growth has slightly outpaced the industry average of 6.9%. Since the same quarter one year prior, revenues rose by 13.8%. This growth in revenue does not appear to have trickled down to the company's bottom line, displayed by a decline in earnings per share.
  • VASC has no debt to speak of therefore resulting in a debt-to-equity ratio of zero, which we consider to be a relatively favorable sign. Along with this, the company maintains a quick ratio of 3.93, which clearly demonstrates the ability to cover short-term cash needs.
  • The gross profit margin for VASCULAR SOLUTIONS INC is rather high; currently it is at 68.48%. Regardless of VASC's high profit margin, it has managed to decrease from the same period last year. Despite the mixed results of the gross profit margin, VASC's net profit margin of -0.64% significantly underperformed when compared to the industry average.
  • The company's current return on equity has slightly decreased from the same quarter one year prior. This implies a minor weakness in the organization. When compared to other companies in the Health Care Equipment & Supplies industry and the overall market, VASCULAR SOLUTIONS INC's return on equity is below that of both the industry average and the S&P 500.
  • Net operating cash flow has significantly decreased to -$4.34 million or 188.46% when compared to the same quarter last year. In addition, when comparing to the industry average, the firm's growth rate is much lower.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.